SEARCH

SEARCH BY CITATION

References

  • 1
    Kumar M, Kesarwani S, Rao A, Garnaik A. Macular folds: an unusual association in topiramate toxicity. Clin Exp Optom 2012; 95: 449452.
  • 2
    Abtahi MA, Abtahi SH, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, Akbari M. Topiramate and the vision: a systematic review. Clin Ophthalmol 2012; 6: 117131.
  • 3
    Guier CP. Elevated intraocular pressure and myopic shift linked to topiramate use. Optom Vis Sci 2007; 84: 10701073.
  • 4
    Dehghani A, Abtahi MA, Abtahi SH, Peyman A, Etemadifar M, Ghanbari H, Mohammadi Z. Massive bilateral choroidal detachment induced by administration of topiramate. Case Report Ophthalmol 2011; 2: 251255.
  • 5
    Abtahi SH, Abtahi MA, Roomizadeh P, Kasaei Z. Discriminación de glaucoma de ángulo cerrado secundario a topiramato del glaucoma primario de ángulo: la tríada de la edad, el patrón de la manifestación clínica y el historial de medicamentos. Arch Soc Esp Oftalmol 2012; http://dx.doi.org/10.1016/j.oftal.2012.05.009.
  • 6
    Abtahi SH, Abtahi MA, Roomizadeh P, Etemadifar M. Use of topiramate and risk of glaucoma: a case-control study. Am J Ophthalmol 2012; 154: 413.
  • 7
    Abtahi SH, Abtahi MA, Fazel F, Roomizadeh P. Linkage of topiramate and the central corneal thickening. J Ocul Pharmacol Ther 2012; 28: 209210.
  • 8
    Abtahi SH, Abtahi MA, Etemadifar M, Mazloumi M, Attarzadeh H. Effects of Topiramate on afferent visual pathways: controversies and uncertainties. Neurol Sci 2012; May 19 [Epub ahead of print].